Beyond rituximab: Obinutuzumab and the new era of B-cell-targeted therapy in lupus nephritis. // Nefrología. – URL: https://www.sciencedirect.com/science/article/pii/S0211699526002006?dgcid=rss_sd_all
Beyond rituximab: Obinutuzumab and the new era of B-cell-targeted therapy in lupus nephritis. Nefrología. https://www.sciencedirect.com/science/article/pii/S0211699526002006?dgcid=rss_sd_all
“Beyond rituximab: Obinutuzumab and the new era of B-cell-targeted therapy in lupus nephritis.” Nefrología.
@article{article117415,
title = {Beyond rituximab: Obinutuzumab and the new era of B-cell-targeted therapy in lupus nephritis},
journal = {Nefrología},
url = {https://www.sciencedirect.com/science/article/pii/S0211699526002006?dgcid=rss_sd_all}
}